PillRx only · Tablet · Oral
Mefloquine Hydrochloride
Mefloquine Hydrochloride
3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US3 NDCs
3 active makers
3 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$4.114
Latest avg · Jul 22, 2026
-12%
Since Dec 17, 2025
3
Active US suppliers
75%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
2.7K
Rx · 2026 Q1
18K
Units dispensed
+487%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it3 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Chartwell RX, LLC | unknown | 2 | SUPPLYING |
| Teva Pharmaceuticals USA, Inc. | unknown | 1 | SUPPLYING |
| A-S Medication Solutions | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Apr 2, 2012RECALLRecall (Class II): Mefloquine HCL Tablets, 250 mg, 5 tablets per blister pack; 5 Blister packs per carton, Rx only, Teva Pharmaceuticals U…
Tablet Thickness: Product is being recalled due to the potential of being underweight or overweight. — Recalling firm: Teva Pharmaceuticals USA, Inc. — Nationwide